Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFRMakoto Maemondo, Toshihiro Nukiwa, Akira Inoue et al.|New England Journal of Medicine|2010Cited by 5.6k
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung CancerRiichiroh Maruyama, Masahiro Fukuoka, Masahiro Tsuboi et al.|Journal of Clinical Oncology|2008Cited by 365